{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T09:58:52Z","timestamp":1771581532847,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272321"],"award-info":[{"award-number":["82272321"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2042023kf0230"],"award-info":[{"award-number":["2042023kf0230"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100016359","name":"Zhongnan Hospital of Wuhan University","doi-asserted-by":"crossref","award":["ZNLH201902"],"award-info":[{"award-number":["ZNLH201902"]}],"id":[{"id":"10.13039\/501100016359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13402-024-00955-5","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T14:02:06Z","timestamp":1715868126000},"page":"1757-1778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma"],"prefix":"10.1007","volume":"47","author":[{"given":"Ping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiujin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"955_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Ca-Cancer J. Clin. 71, 209\u2013249 (2021)","journal-title":"Ca-Cancer J. Clin."},{"key":"955_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"W. Chen, R. Zheng, P.D. Baade, S. Zhang, H. Zeng, F. Bray, A. Jemal, X.Q. Yu, J. He, Cancer statistics in China, 2015. Ca-Cancer J. Clin. 66, 115\u2013132 (2016)","journal-title":"Ca-Cancer J. Clin."},{"key":"955_CR3","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","volume":"12","author":"D Du","year":"2022","unstructured":"D. Du, C. Liu, M. Qin, X. Zhang, T. Xi, S. Yuan, H. Hao, J. Xiong, Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm. Sin B 12, 558\u2013580 (2022)","journal-title":"Acta Pharm. Sin B"},{"key":"955_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"H.B. El-Serag, Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142, 1264\u20131273 (2012)","journal-title":"Gastroenterology"},{"key":"955_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41419-022-04563-9","volume":"13","author":"C Zheng","year":"2022","unstructured":"C. Zheng, M. Liu, Y. Ge, Y. Qian, H. Fan, HBx increases chromatin accessibility and ETV4 expression to regulate dishevelled-2 and promote HCC progression. Cell. Death Dis. 13, 116 (2022)","journal-title":"Cell. Death Dis."},{"key":"955_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2005.12.008","volume":"244","author":"W Wei","year":"2006","unstructured":"W. Wei, W. Huang, Y. Pan, F. Zhu, J. Wu, Functional switch of viral protein HBx on cell apoptosis, transformation, and tumorigenesis in association with oncoprotein Ras. Cancer Lett. 244, 119\u2013128 (2006)","journal-title":"Cancer Lett."},{"key":"955_CR7","doi-asserted-by":"crossref","unstructured":"C. Wang, M.D. Wang, P. Cheng, H. Huang, W. Dong, W.W. Zhang, P.P. Li, C. Lin, Z.Y. Pan, M.C. Wu, W.P. Zhou, Hepatitis B virus X protein promotes the stem-like properties of OV6(+) cancer cells in hepatocellular carcinoma. Cell. Death Dis. 8, e2560 (2017)","DOI":"10.1038\/cddis.2016.493"},{"key":"955_CR8","doi-asserted-by":"crossref","unstructured":"K.J. Su, Y.L. Yu, Downregulation of SHIP2 by Hepatitis B Virus X Promotes the Metastasis and Chemoresistance of Hepatocellular Carcinoma through SKP2. Cancers. 11 (2019)","DOI":"10.3390\/cancers11081065"},{"key":"955_CR9","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.7150\/thno.37717","volume":"9","author":"X Lin","year":"2019","unstructured":"X. Lin, S. Zuo, R. Luo, Y. Li, G. Yu, Y. Zou, Y. Zhou, Z. Liu, Y. Liu, Y. Hu, Y. Xie, W. Fang, Z. Liu, HBX-induced miR-5188 impairs FOXO1 to stimulate beta-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma. Theranostics. 9, 7583\u20137598 (2019)","journal-title":"Theranostics"},{"key":"955_CR10","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.1111\/febs.16575","volume":"289","author":"MA Popescu","year":"2022","unstructured":"M.A. Popescu, D. Patriche, M.O. Dobrica, A.M. Pantazica, A.P. Flintoaca, Y. Rouille, C.I. Popescu, Branza-Nichita, Sac1 phosphatidylinositol 4-phosphate phosphatase is a novel host cell factor regulating hepatitis B virus particles assembly and release. Febs J. 289, 7486\u20137499 (2022)","journal-title":"Febs J."},{"key":"955_CR11","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jcmgh.2022.10.008","volume":"15","author":"YY Li","year":"2023","unstructured":"Y.Y. Li, K. Kuroki, T. Shimakami, K. Murai, K. Kawaguchi, T. Shirasaki, K. Nio, S. Sugimoto, T. Nishikawa, H. Okada, N. Orita, H. Takayama, Y. Wang, B.P. Thi, A. Ishida, S. Iwabuchi, S. Hashimoto, T. Shimaoka, N. Tabata, M. Watanabe-Takahashi, K. Nishikawa, H. Yanagawa, M. Seiki, K. Matsushima, T. Yamashita, S. Kaneko, M. Honda, Hepatitis B Virus utilizes a Retrograde trafficking Route via the Trans-Golgi Network to avoid lysosomal degradation. Cell. Mol. Gastroenterol. Hepatol. 15, 533\u2013558 (2023)","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semcancer.2021.05.023","volume":"76","author":"F Arnesano","year":"2021","unstructured":"F. Arnesano, G. Natile, Interference between copper transport systems and platinum drugs. Semin Cancer Biol. 76, 173\u2013188 (2021)","journal-title":"Semin Cancer Biol."},{"key":"955_CR13","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1086\/379522","volume":"73","author":"MA Simpson","year":"2003","unstructured":"M.A. Simpson, H. Cross, C. Proukakis, A. Pryde, R. Hershberger, A. Chatonnet, M.A. Patton, A.H. Crosby, Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am. J. Hum. Genet. 73, 1147\u20131156 (2003)","journal-title":"Am. J. Hum. Genet."},{"key":"955_CR14","doi-asserted-by":"publisher","first-page":"9123","DOI":"10.1074\/jbc.M009270200","volume":"276","author":"L Zeitlmann","year":"2001","unstructured":"L. Zeitlmann, P. Sirim, E. Kremmer, W. Kolanus, Cloning of ACP33 as a novel intracellular ligand of CD4. J. Biol. Chem. 276, 9123\u20139132 (2001)","journal-title":"J. Biol. Chem."},{"key":"955_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10048-009-0172-6","volume":"10","author":"MC Hanna","year":"2009","unstructured":"M.C. Hanna, C. Blackstone, Interaction of the SPG21 protein ACP33\/maspardin with the aldehyde dehydrogenase ALDH16A1. Neurogenetics. 10, 217\u2013228 (2009)","journal-title":"Neurogenetics"},{"key":"955_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116, 281\u2013297 (2004)","journal-title":"Cell"},{"key":"955_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.05.011","volume":"21","author":"M Wang","year":"2020","unstructured":"M. Wang, F. Yu, X. Chen, P. Li, K. Wang, The underlying mechanisms of noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma. Mol. Ther. -Nucl Acids. 21, 13\u201327 (2020)","journal-title":"Mol. Ther. -Nucl Acids"},{"key":"955_CR18","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.3748\/wjg.v27.i48.8302","volume":"27","author":"XC Wei","year":"2021","unstructured":"X.C. Wei, Y.R. Xia, P. Zhou, X. Xue, S. Ding, L.J. Liu, F. Zhu, Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J. Gastroenterol. 27, 8302\u20138322 (2021)","journal-title":"World J. Gastroenterol."},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.3892\/or.2015.3936","volume":"33","author":"CY Huang","year":"2015","unstructured":"C.Y. Huang, X.P. Huang, J.Y. Zhu, Z.G. Chen, X.J. Li, X.H. Zhang, S. Huang, J.B. He, F. Lian, Y.N. Zhao, G.B. Wu, Mir-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients. Oncol. Rep. 33, 2889\u20132898 (2015)","journal-title":"Oncol. Rep."},{"key":"955_CR20","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/s41388-019-1117-7","volume":"39","author":"R Zhong","year":"2020","unstructured":"R. Zhong, J. Tian, M. Fu, S. Ma, L. Liu, J. Li, N. Shen, J. Ke, Y. Yang, Y. Gong, Y. Zhu, Y. Wang, J. Gong, J. Chang, P. Lei, X. Cheng, K. Huang, G. Shen, X. Miao, LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene. 39, 1944\u20131956 (2020)","journal-title":"Oncogene"},{"key":"955_CR21","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/med.21574","volume":"39","author":"Q Wu","year":"2019","unstructured":"Q. Wu, W. Wu, B. Fu, L. Shi, X. Wang, K. Kuca, JNK signaling in cancer cell survival. Med. Res. Rev. 39, 2082\u20132104 (2019)","journal-title":"Med. Res. Rev."},{"key":"955_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bcp.2016.10.003","volume":"122","author":"YT Lin","year":"2016","unstructured":"Y.T. Lin, Y.C. Liu, C.C. Chao, Inhibition of JNK and prothymosin-alpha sensitizes hepatocellular carcinoma cells to cisplatin. Biochem. Pharmacol. 122, 80\u201389 (2016)","journal-title":"Biochem. Pharmacol."},{"key":"955_CR23","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-18-3510","volume":"25","author":"Y Liu","year":"2019","unstructured":"Y. Liu, L. Liu, Y. Zhou, P. Zhou, Q. Yan, X. Chen, S. Ding, F. Zhu, CKLF1 enhances inflammation-mediated carcinogenesis and prevents Doxorubicin-Induced apoptosis via IL6\/STAT3 signaling in HCC. Clin. Cancer Res. 25, 4141\u20134154 (2019)","journal-title":"Clin. Cancer Res."},{"key":"955_CR24","doi-asserted-by":"crossref","unstructured":"B.L. Bennett, D.T. Sasaki, B.W. Murray, E.C. O\u2019Leary, S.T. Sakata, W. Xu, J.C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S.S. Bhagwat, A.M. Manning, D.W. Anderson, SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98, 13681\u201313686 (2001)","DOI":"10.1073\/pnas.251194298"},{"key":"955_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-022-01299-y","volume":"8","author":"Z Fang","year":"2023","unstructured":"Z. Fang, H. Xu, J. Duan, B. Ruan, J. Liu, P. Song, J. Ding, C. Xu, Z. Li, K. Dou, L. Wang, Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK\/MAPK in mice. Signal. Transduct. Target. Ther. 8, 94 (2023)","journal-title":"Signal. Transduct. Target. Ther."},{"key":"955_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.emboj.7600931","volume":"25","author":"K Clark","year":"2006","unstructured":"K. Clark, M. Langeslag, B. van Leeuwen, L. Ran, A.G. Ryazanov, C.G. Figdor, W.H. Moolenaar, K. Jalink, F.N. van Leeuwen, TRPM7, a novel regulator of actomyosin contractility and cell adhesion. Embo J. 25, 290\u2013301 (2006)","journal-title":"Embo J."},{"key":"955_CR27","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.redox.2022.102411","volume":"55","author":"R Zhou","year":"2022","unstructured":"R. Zhou, Y. Chen, S. Li, X. Wei, W. Hu, S. Tang, J. Ding, W. Fu, H. Zhang, F. Chen, W. Hao, Y. Lin, R. Zhu, K. Wang, L. Dong, Y. Zhao, X. Feng, F. Chen, C. Ding, W. Hu, TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKCalpha-NOX4 axis. Redox Biol. 55, 102411 (2022)","journal-title":"Redox Biol."},{"key":"955_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cmet.2021.04.002","volume":"33","author":"MR Zanotelli","year":"2021","unstructured":"M.R. Zanotelli, J. Zhang, C.A. Reinhart-King, Mechanoresponsive metabolism in cancer cell migration and metastasis. Cell. Metab. 33, 1307\u20131321 (2021)","journal-title":"Cell. Metab."},{"key":"955_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-021-01397-5","volume":"20","author":"Q Jiang","year":"2021","unstructured":"Q. Jiang, N. Zheng, L. Bu, X. Zhang, X. Zhang, Y. Wu, Y. Su, L. Wang, X. Zhang, S. Ren, X. Dai, D. Wu, W. Xie, W. Wei, Y. Zhu, J. Guo, SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions. Mol. Cancer. 20, 100 (2021)","journal-title":"Mol. Cancer"},{"key":"955_CR30","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1158\/0008-5472.CAN-12-1507","volume":"72","author":"P Qian","year":"2012","unstructured":"P. Qian, A. Banerjee, Z.S. Wu, X. Zhang, H. Wang, V. Pandey, W.J. Zhang, X.F. Lv, S. Tan, P.E. Lobie, T. Zhu, Loss of SNAIL regulated mir-128-2 on chromosome 3p22.3 targets multiple stem cell factors to promote transformation of mammary epithelial cells. Cancer Res. 72, 6036\u20136050 (2012)","journal-title":"Cancer Res."},{"key":"955_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/hep.27551","volume":"61","author":"B Su","year":"2015","unstructured":"B. Su, T. Luo, J. Zhu, J. Fu, X. Zhao, L. Chen, H. Zhang, Y. Ren, L. Yu, X. Yang, M. Wu, G. Feng, S. Li, Y. Chen, H. Wang, Interleukin-1beta\/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent gankyrin activation during hepatocarcinogenesis. Hepatology. 61, 585\u2013597 (2015)","journal-title":"Hepatology"},{"key":"955_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.celrep.2016.03.008","volume":"15","author":"MS Han","year":"2016","unstructured":"M.S. Han, T. Barrett, M.A. Brehm, R.J. Davis, Inflammation mediated by JNK in myeloid cells promotes the development of Hepatitis and Hepatocellular Carcinoma. Cell. Rep. 15, 19\u201326 (2016)","journal-title":"Cell. Rep."},{"key":"955_CR33","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1158\/0008-5472.CAN-21-1259","volume":"82","author":"J Li","year":"2022","unstructured":"J. Li, Z.Q. Hu, S.Y. Yu, L. Mao, Z.J. Zhou, P.C. Wang, Y. Gong, S. Su, J. Zhou, J. Fan, S.L. Zhou, X.W. Huang, CircRPN2 inhibits aerobic glycolysis and metastasis in Hepatocellular Carcinoma. Cancer Res. 82, 1055\u20131069 (2022)","journal-title":"Cancer Res."},{"key":"955_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-022-02302-8","volume":"41","author":"Y Yang","year":"2022","unstructured":"Y. Yang, P. Ren, X. Liu, X. Sun, C. Zhang, X. Du, B. Xing, PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition. J. Exp. Clin. Cancer Res. 41, 101 (2022)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"955_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-018-0681-y","volume":"37","author":"Q Zhang","year":"2018","unstructured":"Q. Zhang, G. Song, L. Yao, Y. Liu, M. Liu, S. Li, H. Tang, miR-3928v is induced by HBx via NF-kappaB\/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J. Exp. Clin. Cancer Res. 37, 14 (2018)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"955_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virusres.2018.01.001","volume":"246","author":"JC Casciano","year":"2018","unstructured":"J.C. Casciano, M.J. Bouchard, Hepatitis B virus X protein modulates cytosolic ca(2+) signaling in primary human hepatocytes. Virus Res. 246, 23\u201327 (2018)","journal-title":"Virus Res."},{"key":"955_CR37","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/jphp.12539","volume":"68","author":"AM Meredith","year":"2016","unstructured":"A.M. Meredith, C.R. Dass, Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J. Pharm. Pharmacol. 68, 729\u2013741 (2016)","journal-title":"J. Pharm. Pharmacol."},{"key":"955_CR38","doi-asserted-by":"crossref","unstructured":"L. Liu, Z. Lv, M. Wang, D. Zhang, D. Liu, F. Zhu, HBV enhances Sorafenib Resistance in Hepatocellular Carcinoma by reducing ferroptosis via SRSF2-Mediated abnormal PCLAF splicing. Int. J. Mol. Sci. 24 (2023)","DOI":"10.3390\/ijms24043263"},{"key":"955_CR39","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/hep.25834","volume":"56","author":"L Liu","year":"2012","unstructured":"L. Liu, X. Chen, S. Xie, C. Zhang, Z. Qiu, F. Zhu, Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation. Hepatology. 56, 1760\u20131769 (2012)","journal-title":"Hepatology"},{"key":"955_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41420-021-00562-5","volume":"7","author":"Y Zhou","year":"2021","unstructured":"Y. Zhou, L. Liu, Y. Liu, P. Zhou, Q. Yan, H. Yu, X. Chen, F. Zhu, Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK\/ERK-mediated metastatic invasiveness and doxorubicin resistance. Cell. Death Discov. 7, 177 (2021)","journal-title":"Cell. Death Discov"},{"key":"955_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.canlet.2014.07.004","volume":"352","author":"K Mao","year":"2014","unstructured":"K. Mao, J. Zhang, C. He, K. Xu, J. Liu, J. Sun, G. Wu, C. Tan, Y. Zeng, J. Wang, Z. Xiao, Restoration of miR-193b sensitizes Hepatitis B virus-associated hepatocellular carcinoma to sorafenib. Cancer Lett. 352, 245\u2013252 (2014)","journal-title":"Cancer Lett."},{"key":"955_CR42","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.ymthe.2021.04.011","volume":"29","author":"W Song","year":"2021","unstructured":"W. Song, C. Zheng, M. Liu, Y. Xu, Y. Qian, Z. Zhang, H. Su, X. Li, H. Wu, P. Gong, Y. Li, H. Fan, TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p. Mol. Ther. 29, 2601\u20132616 (2021)","journal-title":"Mol. Ther."},{"key":"955_CR43","doi-asserted-by":"crossref","unstructured":"L.J. Liu, Z. Lv, X. Xue, Z.Y. Xing, F. Zhu, Canonical WNT signaling activated by WNT7B contributes to L-HBs-Mediated Sorafenib Resistance in Hepatocellular Carcinoma by inhibiting Mitophagy. Cancers 14 (2022)","DOI":"10.3390\/cancers14235781"},{"key":"955_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.7326\/0003-4819-139-1-200307010-00012","volume":"139","author":"S Gupta","year":"2003","unstructured":"S. Gupta, S. Bent, J. Kohlwes, Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann. Intern. Med. 139, 46\u201350 (2003)","journal-title":"Ann. Intern. Med."},{"key":"955_CR45","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.4251\/wjgo.v13.i10.1425","volume":"13","author":"LJ Liu","year":"2021","unstructured":"L.J. Liu, J.M. Liao, F. Zhu, Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors. World J. Gastrointest. Oncol. 13, 1425\u20131439 (2021)","journal-title":"World J. Gastrointest. Oncol."},{"key":"955_CR46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4251\/wjgo.v14.i1.334","volume":"14","author":"XC Wei","year":"2022","unstructured":"X.C. Wei, L.J. Liu, F. Zhu, Exosomes as potential diagnosis and treatment for liver cancer. World J. Gastrointest. Oncol. 14, 334\u2013347 (2022)","journal-title":"World J. Gastrointest. Oncol."},{"key":"955_CR47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10048-010-0252-7","volume":"11","author":"C Soderblom","year":"2010","unstructured":"C. Soderblom, J. Stadler, H. Jupille, C. Blackstone, O. Shupliakov, M.C. Hanna, Targeted disruption of the mast syndrome gene SPG21 in mice impairs Hind limb function and alters axon branching in cultured cortical neurons. Neurogenetics. 11, 369\u2013378 (2010)","journal-title":"Neurogenetics"},{"key":"955_CR48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41419-019-1650-x","volume":"10","author":"Y Li","year":"2019","unstructured":"Y. Li, Y. Fu, X. Hu, L. Sun, D. Tang, N. Li, F. Peng, X.G. Fan, The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1. Cell. Death Dis. 10, 405 (2019)","journal-title":"Cell. Death Dis."},{"key":"955_CR49","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1038\/srep08534","volume":"5","author":"D Yu","year":"2015","unstructured":"D. Yu, B. Green, A. Marrone, Y. Guo, S. Kadlubar, D. Lin, J. Fuscoe, I. Pogribny, B. Ning, Suppression of CYP2C9 by microRNA hsa-mir-128-3p in human liver cells and association with hepatocellular carcinoma. Sci. Rep. 5, 8534 (2015)","journal-title":"Sci. Rep."},{"key":"955_CR50","doi-asserted-by":"crossref","unstructured":"B. Zhang, S. Han, B. Feng, X. Chu, L. Chen, R. Wang, Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma. Exp. Mol. Med. 49, e293 (2017)","DOI":"10.1038\/emm.2016.177"},{"key":"955_CR51","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/cdd.2017.87","volume":"24","author":"SJ Zhou","year":"2017","unstructured":"S.J. Zhou, Y.L. Deng, H.F. Liang, J.C. Jaoude, F.Y. Liu, Hepatitis B virus X protein promotes CREB-mediated activation of miR-3188 and notch signaling in hepatocellular carcinoma. Cell. Death Differ. 24, 1577\u20131587 (2017)","journal-title":"Cell. Death Differ."},{"key":"955_CR52","first-page":"275","volume":"10","author":"MJ Chen","year":"2020","unstructured":"M.J. Chen, D.W. Wu, C.J. Shen, Y.M. Cheng, C.C. Wu, H. Lee, Hepatitis B virus X protein promotes tumor invasion and poor prognosis in hepatocellular carcinoma via phosphorylation of paxillin at serine 178 by activation of the c-Jun NH2-terminal kinase. Am. J. Cancer Res. 10, 275\u2013283 (2020)","journal-title":"Am. J. Cancer Res."},{"key":"955_CR53","doi-asserted-by":"crossref","unstructured":"S. Lin, K. Hoffmann, C. Gao, M. Petrulionis, I. Herr, P. Schemmer, Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK\/c-jun pathway in human hepatocellular carcinoma. J. Pineal Res. 62 (2017)","DOI":"10.1111\/jpi.12398"},{"key":"955_CR54","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.7150\/ijbs.72982","volume":"18","author":"Z Yang","year":"2022","unstructured":"Z. Yang, H. Zhang, M. Yin, Z. Cheng, P. Jiang, M. Feng, B. Liao, Z. Liu, Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways. Int. J. Biol. Sci. 18, 5963\u20135977 (2022)","journal-title":"Int. J. Biol. Sci."},{"key":"955_CR55","doi-asserted-by":"crossref","unstructured":"T. Sakurai, S. Maeda, L. Chang, M. Karin, Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. U. S. A. 103, 10544\u201310551 (2006)","DOI":"10.1073\/pnas.0603499103"},{"key":"955_CR56","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1172\/JCI37156","volume":"118","author":"L Hui","year":"2008","unstructured":"L. Hui, K. Zatloukal, H. Scheuch, E. Stepniak, E.F. Wagner, Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J. Clin. Invest. 118, 3943\u20133953 (2008)","journal-title":"J. Clin. Invest."},{"key":"955_CR57","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nri1415","volume":"4","author":"J Vakkila","year":"2004","unstructured":"J. Vakkila, M.T. Lotze, Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4, 641\u2013648 (2004)","journal-title":"Nat. Rev. Immunol."},{"key":"955_CR58","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1055\/s-2007-1007114","volume":"19","author":"N Fausto","year":"1999","unstructured":"N. Fausto, Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis. 19, 243\u2013252 (1999)","journal-title":"Semin Liver Dis."},{"key":"955_CR59","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jmb.2010.01.014","volume":"396","author":"LT Su","year":"2010","unstructured":"L.T. Su, H.C. Chen, O. Gonzalez-Pagan, J.D. Overton, J. Xie, L. Yue, L.W. Runnels, TRPM7 activates m-calpain by stress-dependent stimulation of p38 MAPK and c-Jun N-terminal kinase. J. Mol. Biol. 396, 858\u2013869 (2010)","journal-title":"J. Mol. Biol."},{"key":"955_CR60","doi-asserted-by":"crossref","unstructured":"Z. Zeng, T. Leng, X. Feng, H. Sun, K. Inoue, L. Zhu, Z.G. Xiong, Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways. Plos One 10, e0119912 (2015)","DOI":"10.1371\/journal.pone.0119912"},{"key":"955_CR61","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/cells3030751","volume":"3","author":"NS Yee","year":"2014","unstructured":"N.S. Yee, A.A. Kazi, R.K. Yee, Cellular and Developmental Biology of TRPM7 Channel-Kinase: implicated roles in Cancer. Cells. 3, 751\u2013777 (2014)","journal-title":"Cells"},{"key":"955_CR62","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.yexcr.2016.09.022","volume":"349","author":"Y Chen","year":"2016","unstructured":"Y. Chen, Y. Yu, S. Sun, Z. Wang, P. Liu, S. Liu, J. Jiang, Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2. Exp. Cell. Res. 349, 68\u201376 (2016)","journal-title":"Cell. Res."},{"key":"955_CR63","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/s41388-019-1140-8","volume":"39","author":"S Voringer","year":"2020","unstructured":"S. Voringer, L. Schreyer, W. Nadolni, M.A. Meier, K. Woerther, C. Mittermeier, S. Ferioli, S. Singer, K. Holzer, S. Zierler, V. Chubanov, B. Liebl, T. Gudermann, S. Muehlich, Inhibition of TRPM7 blocks MRTF\/SRF-dependent transcriptional and tumorigenic activity. Oncogene. 39, 2328\u20132344 (2020)","journal-title":"Oncogene"},{"key":"955_CR64","doi-asserted-by":"publisher","first-page":"121735","DOI":"10.1016\/j.lfs.2023.121735","volume":"324","author":"EH Yousef","year":"2023","unstructured":"E.H. Yousef, E.N. Abo, G.A. El, Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7. Life Sci. 324, 121735 (2023)","journal-title":"Life Sci."},{"key":"955_CR65","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1158\/0008-5472.CAN-06-3096","volume":"67","author":"S Owatari","year":"2007","unstructured":"S. Owatari, S. Akune, M. Komatsu, R. Ikeda, S.D. Firth, X.F. Che, M. Yamamoto, K. Tsujikawa, M. Kitazono, T. Ishizawa, T. Takeuchi, T. Aikou, J.F. Mercer, S. Akiyama, T. Furukawa, Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res. 67, 4860\u20134868 (2007)","journal-title":"Cancer Res."},{"key":"955_CR66","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/1471-2407-8-175","volume":"8","author":"GV Kalayda","year":"2008","unstructured":"G.V. Kalayda, C.H. Wagner, I. Buss, J. Reedijk, U. Jaehde, Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. Bmc Cancer. 8, 175 (2008)","journal-title":"Bmc Cancer"},{"key":"955_CR67","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1038\/s41598-020-65331-3","volume":"10","author":"C Zhao","year":"2020","unstructured":"C. Zhao, R. Guo, F. Guan, S. Ma, M. Li, J. Wu, X. Liu, H. Li, B. Yang, MicroRNA-128-3p enhances the chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Sci. Rep. 10, 9471 (2020)","journal-title":"Sci. Rep."},{"key":"955_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/JHC.S349369","volume":"9","author":"X Xu","year":"2022","unstructured":"X. Xu, W. Jiang, P. Han, J. Zhang, L. Tong, X. Sun, MicroRNA-128-3p mediates Lenvatinib Resistance of Hepatocellular Carcinoma cells by downregulating c-Met. J. Hepatocell Carcinoma. 9, 113\u2013126 (2022)","journal-title":"J. Hepatocell Carcinoma"},{"key":"955_CR69","doi-asserted-by":"publisher","first-page":"15870","DOI":"10.1038\/ncomms15870","volume":"8","author":"J Cai","year":"2017","unstructured":"J. Cai, L. Fang, Y. Huang, R. Li, X. Xu, Z. Hu, L. Zhang, Y. Yang, X. Zhu, H. Zhang, J. Wu, Y. Huang, J. Li, M. Zeng, E. Song, Y. He, L. Zhang, M. Li, Simultaneous overactivation of Wnt\/beta-catenin and TGFbeta signalling by mir-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat. Commun. 8, 15870 (2017)","journal-title":"Nat. Commun."},{"key":"955_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13046-017-0594-1","volume":"36","author":"X Feng","year":"2017","unstructured":"X. Feng, H. Liu, Z. Zhang, Y. Gu, H. Qiu, Z. He, Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells. J. Exp. Clin. Cancer Res. 36, 123 (2017)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"955_CR71","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1158\/1535-7163.MCT-16-0731","volume":"16","author":"M Ashenden","year":"2017","unstructured":"M. Ashenden, A. van Weverwijk, N. Murugaesu, A. Fearns, J. Campbell, Q. Gao, M. Iravani, C.M. Isacke, An in vivo functional screen identifies JNK Signaling as a modulator of chemotherapeutic response in breast Cancer. Mol. Cancer Ther. 16, 1967\u20131978 (2017)","journal-title":"Mol. Cancer Ther."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-00955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-024-00955-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-00955-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T16:12:12Z","timestamp":1728576732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-024-00955-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s13402-024-00955-5","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"1 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were approved by the Animal Ethics Committee of Wuhan University, Wuhan University Center for Animal Experiment\/A3 Laboratory. This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Wuhan University, School of Basic Medical Sciences (Wuhan, China). Written informed consent was obtained from each patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}